Joseph Nano Cardiovascular Disease, Public Health

Global Heart Disease Burden Set to Surge by 2050, Especially in Older Adults and Lower‑Income Regions

A new global projection warns that clogged‑artery heart disease (ischaemic heart disease, or IHD)—the main cause of heart attacks—will keep rising through mid‑century, driven by aging populations and unequal access to prevention and care.  

The big picture

Researchers modeled trends in IHD using the Global Burden of Disease 2021 dataset and country GDP forecasts. Even if current rates merely hold steady, the sheer growth and aging of the world’s population will push case counts substantially higher. By 2050 the world could see: 67.3 million new IHD cases a year, 510 million people living with IHD, 16 million deaths, and 302 million healthy years of life lost (DALYs). That’s +116%, +106%, +80%, and +62%respectively compared with 2021. Figure 1 on page 4 plots these trajectories—and shows how outcomes would shift under optimistic (−1%/year) or pessimistic (+1%/year) scenarios.  

Who faces the greatest risk?

  • Older adults. People aged 70+ drive most of the projected increase. By 2050, the number of people in this age group will more than double to 1.13 billion, amplifying heart‑disease burden in every region. Figure 4 on page 8 illustrates how sharply counts rise after age 70.  
  • Men. Across regions, men carry a higher age‑standardized burden than women, a gap that persists through 2050 (see Figure 6 on page 10).  
  • Lower‑SDI regions. Countries with lower Sociodemographic Index (SDI) levels—reflecting education, income, and fertility—are projected to shoulder much higher burdens than high‑SDI regions. In high‑SDI regions, age‑standardized (population‑adjusted) rates continue to fall, even as total case counts are influenced by aging. Table 2 (page 6) and the maps on page 7 highlight this split.  

Where will trends rise (or fall)?

Most countries are expected to see rising crude incidence, prevalence, deaths, and DALYs. The projection flags China, India, the Russian Federation, Pakistan, Chile, and South Africa as places with especially heavy burdens, while Peru, Norway, Israel, and Portugal show lower prevalence and stronger declines on some measures—likely reflecting earlier prevention, risk‑factor control, and health‑system investments. Pages 5 and 9 discuss these national patterns; page 7 mapsshow increases in crude rates across much of the globe, even where age‑adjusted rates fall.  

Why the numbers climb

  • Population aging: more people living into their 70s, 80s, and 90s.
  • Economic and lifestyle transitions in lower‑ and middle‑income countries that increase exposure to risk factors.
  • Uneven prevention and treatment, with high‑SDI regions benefiting from earlier diagnosis and comprehensive risk‑factor control. (Introduction and Discussion; pages 2–3, 8–9.)  

What this means for readers and policymakers

  • Prevention works—but needs scaling. Falling age‑adjusted rates in high‑SDI regions suggest that controlling blood pressure, lipids, diabetes, and tobacco, improving diet and physical activity, and strengthening primary care can bend the curve. Policies like tobacco control and broader access to essential heart medicines are key in lower‑SDI regions. (Discussion; pages 8–11.)  
  • Act earlier, live longer. The study also notes worrying premature mortality trends in adolescents and young adults in some regions—making youth‑focused risk‑reduction (smoking, blood pressure, air quality, and healthy weight) urgent. (Results; pages 5 and 8–9.)  
  • Plan for aging. Health systems should prepare for more older patients with chronic IHD—expanding cardiac rehab, secondary prevention, and long‑term care. (Results; page 4; Table 2, page 6.)  

Caveats

These are forecasts, not certainties. The model did not explicitly track future changes in specific risk factors (like LDL cholesterol, pollution, or obesity) and did not separate all IHD subtypes; if risk factors worsen, the burden could be underestimated. Still, the approach outperformed a standard demographic model during back‑testing. (Methods, Model validation, and Limitations; pages 3, 6, and 11.)  

Bottom line: Without stronger prevention and fairer access to heart‑health care, the world will face more heart attacks, more disability, and more deaths from ischaemic heart disease by 2050—especially among older adults and in lower‑income regions. The projection underscores a clear path forward: double down on proven prevention, start earlier in life, and close the care gap across countries.  

Source: European Heart Journal – Quality of Care and Clinical Outcomes (2025): “Global burden of ischaemic heart disease from 2022 to 2050.” See the graphical abstract on page 2 and Figure 1 on page 4 for at‑a‑glance trends.  

Shi, H., Xia, Y., Cheng, Y., Liang, P., Cheng, M., Zhang, B., Liang, Z., Wang, Y., & Xie, W. (2025). Global burden of ischaemic heart disease from 2022 to 2050: projections of incidence, prevalence, deaths, and disability-adjusted life years. European heart journal. Quality of care & clinical outcomes, 11(4), 355–366. https://doi.org/10.1093/ehjqcco/qcae049

Editor’s note: This article is for information only and is not a substitute for professional medical advice.